Silexion Therapeutics prices new warrants exercise deal at $0.50 to raise $1M

* Silexion Therapeutics (SLXN [https://seekingalpha.com/symbol/SLXN]) announced on Friday that it has signed an agreement for the immediate exercise of around 2M outstanding warrants at a reduced price of $0.50 per share.
* The deal is expected to raise around $1M in gross proceeds before fees and expenses for the company.
* As part of the deal, Silexion Therapeutics will issue new Series C warrants for about 2.05M shares and Series D warrants for about 1.95M shares, both priced at $0.50 per share.
* The new warrants will become exercisable after shareholder approval. Series C warrants will expire after 5 years, while Series D warrants will expire after 24 months.
* The deal is expected to close around May 18, 2026, subject to customary conditions.
* The net proceeds will mainly be used for working capital and other general corporate purposes.
* Source: Press Release [https://seekingalpha.com/pr/20517211-silexion-therapeutics-announces-exercise-of-warrants-for-1-million-gross-proceeds]

MORE ON SILEXION THERAPEUTICS

* Seeking Alpha’s Quant Rating on Silexion Therapeutics [https://seekingalpha.com/symbol/SLXN/ratings/quant-ratings]
* Historical earnings data for Silexion Therapeutics [https://seekingalpha.com/symbol/SLXN/earnings]
* Financial information for Silexion Therapeutics [https://seekingalpha.com/symbol/SLXN/income-statement]